Slingshot members are tracking this event:

Regeneron (REGN) and Sanofi (SNY) rheumatoid arthritis drug Kevzara (sarilumab) granted FDA approval

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
High Medium Low
Impact on Stocks
REGN Community voting in process
SNY Community voting in process
Slingshot Insights Explained
Catalyst Date
Occurred on:
May 22, 2017
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Kevzara (sarilumab), Rheumatoid Arthritis, Fda Approval